Overall survival according to KRASmutation status.
P value: P value from log-rank test. HR (FTD/TPI versus placebo) and 95% CI obtained from a distinct unstratified Cox model for each subgroup. P val. inter: P value from unstratified Cox model including arm treatment, subgroup and their interaction in the model. Ties handling method: Efron.
CI, confidence interval; FTD/TPI, trifluridine/tipiracil; HR, hazard ratio; OS, overall survival.